FDA
-
-
-
-
-
-
-
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
-
-
-
-
-
-
-
Piper Sandler: 'Biotech Has a Heartbeat: 17 Stocks to Own Through YE25'
-
-
-
-
-
-
-
CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
-
-
-
-
-
-
-
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual Meeting
-
-
-
-
-
-
-
CG Oncology(CGON) Announces Publication of Final Results from CORE-001 Study
-
-
-
-
323,580 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

